Vaniqa Cream ^*

Vaniqa Cream begins to show results at different times for each person. Improvement may be seen as early as 4 to 8 weeks after starting treatment. Consistent use is key to achieving the best results. If no benefit is seen after 6 months of use, you should discontinue the cream and consult your healthcare provider for alternative options.

If you stop using Vaniqa Cream, its effects will reverse over time. Hair growth will likely return to the rate it was at before you started the treatment. This typically happens within about two months after discontinuing use. Vaniqa controls the condition but does not cure it, so continuous use is necessary to maintain the results.

Vaniqa Cream does not permanently remove hair or stop its growth entirely. It is a treatment that slows down the growth of unwanted facial hair. You will need to continue with your regular hair removal methods, like shaving or tweezing. However, you may find that you need to perform these methods less frequently while using the cream.

You can use makeup and sunscreen while treating your skin with Vaniqa Cream. After applying Vaniqa, you should wait at least five minutes for it to absorb fully and for your skin to dry. Once it is dry, you can apply your cosmetics or sunscreen over the treated areas without interfering with the medication's effectiveness.

If you miss a dose of Vaniqa Cream, you should apply it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed one and resume your regular application schedule. Do not apply a double dose to make up for the one you missed, as this can increase the risk of skin irritation.

Vaniqa Cream is specifically studied and approved for use on the face and the area under the chin. Its safety and effectiveness have not been established for use on other parts of the body. You should not apply this cream to other areas unless specifically instructed to do so by your doctor. It is intended for facial hirsutism only.

Vaniqa Cream is not indicated for use by men. The clinical studies for this medication were conducted on women to treat facial hirsutism. The excessive hair growth it treats is typically associated with female hormonal conditions. Therefore, its safety and efficacy in men have not been evaluated, and it is not recommended for them.

Vaniqa Cream is considered safe for long-term, continuous use when prescribed by a healthcare provider. Clinical studies have evaluated its use for periods up to one year, showing it to be well-tolerated by most women. Since hirsutism is often a chronic condition, ongoing treatment is usually necessary to maintain the reduction in hair growth. Always follow your doctor's advice.

You can definitely develop hirsutism without having Polycystic Ovary Syndrome (PCOS). While PCOS is a very common cause, Vaniqa is effective for hirsutism from various origins. Other causes can include different hormonal conditions, certain medications, or even genetic factors. Sometimes, the specific cause of hirsutism cannot be identified, which is known as idiopathic hirsutism.

Vaniqa Cream should be stored at a controlled room temperature, away from direct sunlight and moisture. Make sure the cap is screwed on tightly after each use to prevent the cream from drying out. Do not freeze the product. Keeping it in a cool, dry place like a medicine cabinet is ideal for maintaining its effectiveness.

Vaniqa Cream is not generally recommended for women who are pregnant or breastfeeding. It is not known if the active ingredient, eflornithine, can harm a developing baby or pass into breast milk. If you are pregnant, planning to become pregnant, or breastfeeding, you must consult your doctor to discuss the potential risks and benefits before using this medication.

The Vaniqa Cream from IsraelPharm has an 11.5% strength label, which is bioequivalent to the 13.9% strength available in the USA. Different regions use different methods to measure the active ingredient concentration (base vs. hydrochloride salt). Both versions contain the same amount of eflornithine and provide the same therapeutic effect. They are simply labeled according to different local regulations.